| The Pharmaceutical
Journal Vol 267 No 7155 p3-8 July 7, 2001 |
Research and Development summary Recombinant urate oxidase prevents
hyperuricaemia after tumour cell lysis TREATMENT of hyperuricaemia,
a potentially life-threatening complication associated with the treatment
of haematological malignancies, is set to improve as clinical trials show
encouraging results with recombinant urate oxidase (rasburicase)...[more] |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal